Viewing Study NCT01328366


Ignite Creation Date: 2025-12-24 @ 4:05 PM
Ignite Modification Date: 2026-02-01 @ 2:30 PM
Study NCT ID: NCT01328366
Status: COMPLETED
Last Update Posted: 2015-07-09
First Post: 2011-04-01
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Quality of Life and Psychosocial Factors Associated With Severe Psoriasis Following Treatment With Adalimumab
Sponsor: AbbVie (prior sponsor, Abbott)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Psoriasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Quality of Life View
None Psychosocial factors View